#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Maeve Duffy Email
Head Programs and Clinical Operations . Syndesi Therapeutics
Louvain-la-Neuve,
Locationm**********@syndesitherapeutics.com
Primary EmailHow to contact Maeve Duffy
Join and see Maeve's contact info for free!Current Roles
Employees:
20Revenue:
$3.1MAbout
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer's Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.Syndesi Therapeutics Address
Louvain-la-Neuve, null